Back to search
Multi-Drug Resistant Hiv-1 Infection
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-Drug Resistant Hiv-1 Infection trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Multi-Drug Resistant Hiv-1 Infection trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this study is to address the gap in published data on viral suppression among people meeting the criteria for virologic failure on dolutegravir (DTG…
The PRESTIGIO Registry is an Observational, prospective, multicentre study that includes patients, regularly followed by Italian Infectious Disease Centres, wit…
The purpose of this study is to determine whether the BMS Attachment Inhibitor (BMS-663068) is effective in the treatment of heavily treatment experienced HIV-1…
In the SHIELD study, the study sponsor seeks to assess safety, PK and antiviral activity for children and adolescents with dual or triple class resistance. It w…